Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 12 de 12
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
Ir J Med Sci ; 185(4): 779-783, 2016 Nov.
Article de Anglais | MEDLINE | ID: mdl-26159430

RÉSUMÉ

OBJECTIVE: To describe the shared care and outcomes of patients with periocular skin tumours who underwent Mohs micrographic surgery (MMS) performed by dermatologists, followed by oculoplastic reconstruction undertaken by ophthalmologists at two teaching and one private hospital in Ireland. RESEARCH DESIGN AND METHODS: This was a retrospective chart review at the Royal Victoria Eye and Ear Hospital, St James Hospital and the Hermitage Clinic. RESULTS: One hundred and twenty seven patients had periocular Mohs surgery between November 2006 and January 2013 mainly indicated for basal cell carcinoma. The mean follow-up time was 2 years and to date there have been no local recurrences. CONCLUSIONS: MMS is available in Ireland and should be considered for patients with facial tumours in the ocular region.


Sujet(s)
Carcinome basocellulaire/chirurgie , Tumeurs de la face/chirurgie , Chirurgie de Mohs/méthodes , Tumeurs cutanées/chirurgie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Dermatologues , Femelle , Humains , Irlande , Mâle , Adulte d'âge moyen , Ophtalmologistes , Études rétrospectives , Tumeurs cutanées/anatomopathologie , Résultat thérapeutique
5.
Br J Dermatol ; 162(3): 607-10, 2010 Mar.
Article de Anglais | MEDLINE | ID: mdl-19906070

RÉSUMÉ

BACKGROUND: Histology reports of skin tumour excisions frequently describe a histological margin significantly less than the planned surgical excision margin. OBJECTIVES: A novel method of marking visible tumour margin was devised. This allowed us to evaluate the accuracy of tumour detection and to compare tissue contraction of the clinically normal perilesional skin with that of tumour tissue following excision and fixation. METHODS: Forty-four well-defined basal cell carcinomas were excised from 42 patients. The visible tumour edge was marked by scoring with a blade around its circumference prior to excision. This allowed comparison of visible and true histological tumour margin. The excision margin was carefully measured from the scored line and the tumour excised. After tissue fixation and processing the histological dimensions of tumour and perilesional margin skin were compared with the pre-excision measurements. RESULTS: The tumour edge was accurately identified to within 1 mm in 67% of margins and was underestimated in only 4%. The whole specimen contracted by a mean of 14%. Skin containing tumour contracted by a mean of 11% but adjacent tumour-free skin in the same plane contracted by a mean of 19%. There was no significant effect of age and site on difference in percentage shrinkage between tumour and margin. CONCLUSIONS: We underestimated tumour extent at only 4% of margins. Tissue shrinkage was the most important factor affecting eventual histological margin. Our novel technique allowed us to demonstrate that this shrinkage is not uniform across the specimen, but is disproportionately high in the tumour-free margin. This suggests that previous estimates of margin shrinkage, based on whole-specimen contraction measurements, may have been erroneously low.


Sujet(s)
Carcinome basocellulaire/chirurgie , Tumeurs cutanées/chirurgie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Carcinome basocellulaire/anatomopathologie , Humains , Adulte d'âge moyen , États précancéreux/anatomopathologie , États précancéreux/chirurgie , Appréciation des risques , Sensibilité et spécificité , Tumeurs cutanées/anatomopathologie , Statistiques comme sujet , Charge tumorale
9.
Br J Dermatol ; 146(2): 304-7, 2002 Feb.
Article de Anglais | MEDLINE | ID: mdl-11903244

RÉSUMÉ

BACKGROUND: A specialist patch test clinic was set up in April 1997 at the Department of Dermatology, South Infirmary-Victoria Hospital, Cork, Ireland. The number of batteries available was expanded from six to 21 and the routine testing of patients to their own products was introduced, as was prick testing for latex hypersensitivity. OBJECTIVES: To assess the impact of introducing this clinic on the detection of allergic contact dermatitis. METHODS: Patch test results for the first full year of operation of the clinic (1998) were compared with those in the year prior to setting it up (1996). RESULTS: Although the number of patients tested rose after the introduction of the new clinic, the difference was not significant as the number of new dermatology general referrals had also risen. Thirty-one of the 91 patients tested in 1996 had positive patch tests compared with 84 of 158 tested in 1998 (P = 0.0036). Eighteen allergens were detected in 1996 and 53 in 1998. Two patients were positive to their own products in 1996, compared with 12 in 1998 (P = 0.04). The commercial batteries were negative in four of these cases. Three cases of latex hypersensitivity were detected in 1998. CONCLUSIONS: The introduction of a specialist patch test clinic resulted in an increase in detected cases of allergic contact dermatitis. The larger range of batteries available and the more widespread testing of patients' own products were the principal factors involved.


Sujet(s)
Eczéma de contact allergique/diagnostic , Services de consultations externes des hôpitaux , Tests épicutanés/méthodes , Allergènes/immunologie , Humains , Irlande , Hypersensibilité au latex/diagnostic
10.
Dermatol Clin ; 16(4): 853-7, xvi, 1998 Oct.
Article de Anglais | MEDLINE | ID: mdl-9891694
11.
J Pharmacol Exp Ther ; 262(1): 246-51, 1992 Jul.
Article de Anglais | MEDLINE | ID: mdl-1385629

RÉSUMÉ

Plasma atrial natriuretic peptide (ANP) concentrations were monitored in two experimental models of protection from cisplatin nephrotoxicity. Sprague-Dawley rats made diabetic with streptozotocin (65 mg/kg) were protected from cisplatin-induced nephrotoxicity when compared to control rats as indicated by reduced plasma creatinine (0.49 +/- 0.02 vs. 0.9 +/- 0.06 mg/dl; P less than .001) and blood urea nitrogen concentrations (18.51 +/- 1.4 vs. 43.08 +/- 2.1 mg/dl; P less than .001). Plasma ANP was also increased with experimental diabetes (76.5 +/- 8.98 fmol/ml) vs. normoglycemic controls (43.8 +/- 8.9 fmol/ml; P less than .02). When diabetic rats were treated with insulin, the renal protection observed with the diabetic state was reversed (creatinine, 0.70 +/- .05 mg/dl); plasma ANP concentrations were also reduced (52.2 +/- 15.2 fmol/ml). Renal platinum concentrations were significantly lower in the diabetic group and the reversal of diabetic-induced renal protection with insulin was associated with increased renal platinum concentrations. In rats given a single i.p. dose of cisplatin (5 mg/kg), a reduction in cisplatin-induced nephrotoxicity was observed when 5% NaCl was the vehicle of choice compared to that seen in rats given the same dose of drug in 0.9% saline (creatinine, 0.43 +/- 0.07 with 5% NaCl vs. 0.63 +/- 0.03 with 0.09% NaCl). NaCl (5%) administration also resulted in increased plasma ANP concentrations when compared to rats receiving equivalent volumes of 0.9% NaCl (88.4 +/- 6.2 vs. 50.5 +/- 5.6 fmol/ml, respectively). These data suggest that increased endogenous ANP may be a mechanism of renal protection common to both experimental diabetes and hypertonic saline administration. Chronically increased ANP may prevent renal accumulation of platinum in the kidney.


Sujet(s)
Facteur atrial natriurétique/sang , Cisplatine/toxicité , Diabète expérimental/métabolisme , Rein/effets des médicaments et des substances chimiques , Animaux , Glycémie , Créatinine/sang , Diabète expérimental/traitement médicamenteux , Insuline/administration et posologie , Rein/métabolisme , Mâle , Platine/analyse , Rats , Lignées consanguines de rats
12.
Arch Toxicol ; 59(1): 12-5, 1986 May.
Article de Anglais | MEDLINE | ID: mdl-3741137

RÉSUMÉ

N-acetyl-S-pentachloro-1,3-butadienyl-L-cysteine (PCBD-NAC) is a postulated metabolite derived from glutathione conjugation of hexachloro-1,3-butadiene and is nephrotoxic in the rat. Because PCBD-NAC causes selective necrosis to the pars recta of the proximal tubule, and is an organic anion it might be expected to be transported by the renal organic anion transport system. Rat renal cortical slices were used to characterise the transport. 14C-PCBD-NAC uptake was temperature dependent and reduced by the metabolic inhibitors cyanide and iodoacetate. Probenecid and sulphinpyrazone, specific competitive inhibitors of the anion transport system, and dinitrophenol, a metabolic inhibitor as well as a competitive inhibitor of anion transport, reduced PCBD-NAC transport. Organic cations or uric acid transport inhibitors did not alter PCBD-NAC accumulation by the slices. These data are consistent with the transport of PCBD-NAC by the renal organic anion secretory system.


Sujet(s)
Acétylcystéine/analogues et dérivés , Butadiènes/métabolisme , Cystéine/analogues et dérivés , Cortex rénal/métabolisme , Animaux , Antimétabolites/pharmacologie , Transport biologique actif , Cystéine/métabolisme , Femelle , Cinétique , Rats , Lignées consanguines de rats , Température
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE